KR20220167128A - Health assistance food composition showing fatigue recovery and energy improvement effect and intake method of the composition - Google Patents
Health assistance food composition showing fatigue recovery and energy improvement effect and intake method of the composition Download PDFInfo
- Publication number
- KR20220167128A KR20220167128A KR1020210076281A KR20210076281A KR20220167128A KR 20220167128 A KR20220167128 A KR 20220167128A KR 1020210076281 A KR1020210076281 A KR 1020210076281A KR 20210076281 A KR20210076281 A KR 20210076281A KR 20220167128 A KR20220167128 A KR 20220167128A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- health supplement
- supplement composition
- composition containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 109
- 238000000034 method Methods 0.000 title claims abstract description 28
- 235000013305 food Nutrition 0.000 title claims description 7
- 230000000694 effects Effects 0.000 title abstract description 45
- 238000011084 recovery Methods 0.000 title abstract description 13
- 230000006872 improvement Effects 0.000 title abstract description 9
- 230000036541 health Effects 0.000 title description 3
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 80
- 241000383638 Allium nigrum Species 0.000 claims abstract description 47
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 44
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 44
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 44
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 25
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 20
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 16
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 claims description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 14
- 241000320380 Silybum Species 0.000 claims description 13
- 235000010841 Silybum marianum Nutrition 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 12
- 235000019152 folic acid Nutrition 0.000 claims description 12
- 239000011724 folic acid Substances 0.000 claims description 12
- 229960000304 folic acid Drugs 0.000 claims description 12
- 229940088594 vitamin Drugs 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 12
- 235000013343 vitamin Nutrition 0.000 claims description 12
- 239000011782 vitamin Substances 0.000 claims description 12
- 235000019156 vitamin B Nutrition 0.000 claims description 12
- 239000011720 vitamin B Substances 0.000 claims description 12
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 11
- 229930003270 Vitamin B Natural products 0.000 claims description 11
- 239000011701 zinc Substances 0.000 claims description 11
- 229910052725 zinc Inorganic materials 0.000 claims description 11
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 10
- 229930064664 L-arginine Natural products 0.000 claims description 10
- 235000014852 L-arginine Nutrition 0.000 claims description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- 235000019161 pantothenic acid Nutrition 0.000 claims description 10
- 239000011713 pantothenic acid Substances 0.000 claims description 10
- 229940055726 pantothenic acid Drugs 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 235000011649 selenium Nutrition 0.000 claims description 10
- 239000011669 selenium Substances 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- 229940091258 selenium supplement Drugs 0.000 claims description 10
- 235000005152 nicotinamide Nutrition 0.000 claims description 9
- 239000011570 nicotinamide Substances 0.000 claims description 9
- 229960002666 1-octacosanol Drugs 0.000 claims description 8
- 229940119485 safflower extract Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 229930003451 Vitamin B1 Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229960003495 thiamine Drugs 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- 235000010374 vitamin B1 Nutrition 0.000 claims description 7
- 239000011691 vitamin B1 Substances 0.000 claims description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 235000005282 vitamin D3 Nutrition 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 229940021056 vitamin d3 Drugs 0.000 claims description 6
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims description 5
- 240000008886 Ceratonia siliqua Species 0.000 claims description 5
- 241000973495 Odax pullus Species 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 description 18
- 238000003860 storage Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000007103 stamina Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 240000002234 Allium sativum Species 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000004611 garlic Nutrition 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- OIXLLKLZKCBCPS-RZVRUWJTSA-N (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CCCNC(N)=N OIXLLKLZKCBCPS-RZVRUWJTSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010071289 Lower urinary tract symptoms Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000019896 Motor Skills disease Diseases 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001274189 Pomatomus saltatrix Species 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 208000003056 Vitamin B6 deficiency Diseases 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000003840 blood vessel health Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000000260 male genitalia Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- -1 sulfur amino acids Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0606—Arginine
Abstract
Description
본 발명은 건강보조식품 조성물 및 그 조성물의 섭취방법에 관한 것으로, 더욱 상세하게는 영양성분이 풍부하게 함유되어 있을 뿐만 아니라, 취식자의 피로를 회복시키고 정력을 개선하는 효과를 나타내는 건강보조식품 조성물 및 그 조성물의 섭취방법에 관한 것이다.The present invention relates to a health supplement composition and a method of ingesting the composition, and more particularly, to a health supplement composition that is rich in nutrients and exhibits an effect of recovering the fatigue of eaters and improving stamina, and It relates to a method of ingesting the composition.
일반적으로 식품은 영양공급원으로서 가치를 지닐 뿐 아니라 기호성을 충족시킬 수 있는 수단이 될 수도 있고, 특정한 약리 효과를 나타내는 경우에는 치료제의 원료로 사용되기도 한다.In general, food not only has value as a source of nutrition, but also can be a means to satisfy palatability, and is also used as a raw material for therapeutic agents when it exhibits specific pharmacological effects.
또한, 식품은 건강증진효과를 얻을 수 있는 수단으로서도 유용하여, 최근에는 만성적인 질환을 앓고 있는 환자는 물론, 건강에 대한 관심이 높은 일반의 사람들까지도 기능성 식품을 건강보조제로서 흔히 섭취하고 있다.In addition, food is also useful as a means to obtain a health promotion effect, and recently, patients suffering from chronic diseases as well as general people with high interest in health often consume functional foods as health supplements.
그러나 기능성 식품이 취식이 불편한 형태를 취할 경우에는 꾸준한 섭취를 위하여 많은 인내심을 요하므로, 차나 음료, 환과 같은 취식이 간편한 형태가 바람직한 반면, 이 경우 재료 자체의 맛이 그대로 전달되므로 어떤 재료를 선택하느냐에 따라 기호성이 크게 달라질 수밖에 없다.However, when functional foods take a form that is inconvenient to eat, a lot of patience is required for steady intake. So, while easy-to-eat forms such as tea, beverages, and pills are desirable, in this case, the taste of the ingredient itself is conveyed as it is, so it depends on which ingredient you choose. Depending on the preference, the preference will inevitably vary greatly.
한편, 연구결과에 의하면 인간의 정력은 노후까지 지속되는 것으로 알려져 있는데, 사회생활이 복잡해지고 경쟁사회에서 살아나기 위해 많은 스트레스에 노출되는 현대인의 경우 체력쇠약, 원기부족 현상이 발생되고 있으며, 이로 인해 정력감퇴로 이루어지고 있다.On the other hand, according to research results, it is known that human energy lasts until old age. In the case of modern people who are exposed to a lot of stress to survive in a complicated social life and competitive society, physical weakness and lack of energy are occurring. It is made up of energy loss.
서양에서는 남성의 약해진 정력치료제로서 비아그라가 널리 알려져서 애용되고 있다. 그러나 이러한 제제는 신경쇠약이나 혈관장애 등으로 인한 기질적인 원인을 치료하거나 스트레스를 해소하고 저하된 체력을 정상화시켜 원기를 회복함으로써 임포텐스(impotence 발기장애)를 치료하는 것이 아니고 필요한 순간만 혈류를 증강시켜 주어 임포텐스를 해소하는 것에 불과하며, 종래에는 정력강화용 링이나 속옷과 같이 기구적인 정력강화 제품이 대부분이었다.In the West, Viagra is widely known and used as a remedy for men's weakened virility. However, these agents do not cure impotence (impotence erectile dysfunction) by treating organic causes such as nervous breakdown or vascular disorders, relieving stress and normalizing reduced physical strength, but enhancing blood flow only at the necessary moment. It is only to relieve the impotence given, and in the past, most of the mechanical strength enhancement products such as rings or underwear for strength enhancement were used.
본 발명의 목적은 영양성분이 풍부하게 함유되어 있을 뿐만 아니라, 취식자의 피로를 회복시키고 정력을 개선하는 효과를 나타내는 건강보조식품 조성물 및 그 조성물의 섭취방법에 관한 것이다.An object of the present invention relates to a health supplement composition and a method of ingesting the composition, which not only contain abundant nutrients, but also show the effect of recovering the fatigue of eaters and improving their stamina.
본 발명의 목적은 흑마늘, L-아르기닌, 비타민 B 혼합물, 니코틴산아미드, 판토텐산, 엽산 및 셀레늄으로 이루어지는 것을 특징으로 하는 흑마늘이 함유된 건강보조식품 조성물을 제공함에 의해 달성된다.An object of the present invention is achieved by providing a health supplement composition containing black garlic, characterized in that it consists of black garlic, L-arginine, vitamin B mixture, nicotinic acid amide, pantothenic acid, folic acid and selenium.
본 발명의 바람직한 특징에 따르면, 상기 흑마늘이 함유된 건강보조식품 조성물은 흑마늘 100 중량부, L-아르기닌 60 내지 70 중량부, 비타민 B 혼합물 0.3001 내지 0.701 중량부, 니코틴산아미드 4 내지 6 중량부, 판토텐산 0.5 내지 1 중량부, 엽산 0.01 내지 0.1 중량부 및 셀레늄 0.0001 내지 0.0003 중량부로 이루어지는 것으로 한다.According to a preferred feature of the present invention, the health supplement composition containing black garlic is 100 parts by weight of black garlic, 60 to 70 parts by weight of L-arginine, 0.3001 to 0.701 parts by weight of vitamin B mixture, 4 to 6 parts by weight of nicotinic acid amide, pantothenic acid 0.5 to 1 part by weight, 0.01 to 0.1 part by weight of folic acid and 0.0001 to 0.0003 part by weight of selenium.
본 발명의 더 바람직한 특징에 따르면, 상기 비타민 B 혼합물은 비타민 B1 0.1 내지 0.3 중량부, 비타민 B6 0.2 내지 0.4 중량부 및 비타민 B12 0.0001 내지 0.001 중량부로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the vitamin B mixture consists of 0.1 to 0.3 parts by weight of vitamin B1, 0.2 to 0.4 parts by weight of vitamin B6, and 0.0001 to 0.001 parts by weight of vitamin B12.
본 발명의 더욱 바람직한 특징에 따르면, 상기 흑마늘이 함유된 건강보조식품 조성물에는 상기 흑마늘 100 중량부 대비 녹골추출물 및 홍화추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어진 첨가제 1 내지 3 중량부가 더 함유되는 것으로 한다.According to a more preferred feature of the present invention, the black garlic-containing health supplement composition further contains 1 to 3 parts by weight of an additive consisting of at least one selected from the group consisting of a green bone extract and a safflower extract relative to 100 parts by weight of the black garlic .
또한, 본 발명의 목적은 블랙마카, 밀크씨슬, 옥타코사놀, 아연, 비타민 혼합물로 이루어지는 것을 특징으로 하는 블랙마카가 함유된 건강보조식품 조성물을 제공함에 의해서도 달성될 수 있다.In addition, the object of the present invention can be achieved by providing a health supplement composition containing black maca, characterized in that it consists of a mixture of black maca, milk thistle, octacosanol, zinc, and vitamins.
본 발명의 바람직한 특징에 따르면, 상기 블랙마카가 함유된 건강보조식품 조성물은 블랙마카 100 중량부, 밀크씨슬 40 내지 50 중량부, 옥타코사놀 3 내지 4 중량부, 아연 3 내지 4 중량부 및 비타민 혼합물 0.002 내지 0.003 중량부로 이루어지는 것으로 한다.According to a preferred feature of the present invention, the health supplement composition containing black maca contains 100 parts by weight of black maca, 40 to 50 parts by weight of milk thistle, 3 to 4 parts by weight of octacosanol, 3 to 4 parts by weight of zinc, and a vitamin mixture. It is made of 0.002 to 0.003 parts by weight.
본 발명의 더 바람직한 특징에 따르면, 상기 비타민 혼합물은 비타민 D3 0.0015 내지 0.0025 중량부 및 비타민 E 0.0005 내지 0.005 중량부로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the vitamin mixture is composed of 0.0015 to 0.0025 parts by weight of vitamin D3 and 0.0005 to 0.005 parts by weight of vitamin E.
본 발명의 더욱 바람직한 특징에 따르면, 상기 블랙마카가 함유된 건강보조식품 조성물에는 상기 블랙마카 100 중량부 대비 캐롭추출물 1 내지 3 중량부가 더 함유되는 것으로 한다.According to a more preferred feature of the present invention, the health supplement composition containing black maca further contains 1 to 3 parts by weight of carob extract relative to 100 parts by weight of black maca.
또한, 본 발명의 목적은 상기 흑마늘이 함유된 건강보조식품 조성물 0.9 내지 1.1g을 섭취하고 약 10 내지 14시간 후에, 상기 블랙마카가 함유된 건강보조식품 조성물 0.8 내지 1g을 섭취하는 것을 특징으로 하는 건강보조식품 조성물의 섭취방법을 제공함에 의해서도 달성될 수 있다.In addition, an object of the present invention is to ingest 0.9 to 1.1 g of the health supplement composition containing the black garlic and about 10 to 14 hours later, to ingest 0.8 to 1 g of the health supplement composition containing the black maca. It can also be achieved by providing a method of ingesting the health supplement composition.
본 발명에 따른 건강보조식품 조성물 및 그 조성물의 섭취방법은 영양성분이 풍부하게 함유되어 있을 뿐만 아니라, 취식자의 피로를 회복시키고 정력을 개선하는 탁월한 효과를 나타낸다.The health supplement composition and the method of ingesting the composition according to the present invention not only contain abundant nutrients, but also exhibit excellent effects of recovering the wearer's fatigue and improving stamina.
도 1은 본 발명에 따른 건강보조식품 조성물을 보관하는데 사용될 수 있는 보관케이스를 나타낸 사시도이다.1 is a perspective view showing a storage case that can be used to store a health supplement composition according to the present invention.
이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다.Hereinafter, a preferred embodiment of the present invention and the physical properties of each component will be described in detail, but this is to be explained in detail so that a person having ordinary knowledge in the art to which the present invention belongs can easily practice the invention, This is not meant to limit the technical spirit and scope of the present invention.
본 발명에 따른 흑마늘이 함유된 건강보조식품 조성물은 흑마늘, L-아르기닌, 비타민 B 혼합물, 니코틴산아미드, 판토텐산, 엽산 및 셀레늄으로 이루어지며, 흑마늘 100 중량부, L-아르기닌 60 내지 70 중량부, 비타민 B 혼합물 0.3001 내지 0.701 중량부, 니코틴산아미드 4 내지 6 중량부, 판토텐산 0.5 내지 1 중량부, 엽산 0.01 내지 0.1 중량부 및 셀레늄 0.0001 내지 0.0003 중량부로 이루어지는 것이 바람직하다.The health supplement composition containing black garlic according to the present invention consists of black garlic, L-arginine, vitamin B mixture, nicotinic acid amide, pantothenic acid, folic acid and selenium, 100 parts by weight of black garlic, 60 to 70 parts by weight of L-arginine, vitamins It is preferably composed of 0.3001 to 0.701 parts by weight of B mixture, 4 to 6 parts by weight of nicotinamide, 0.5 to 1 part by weight of pantothenic acid, 0.01 to 0.1 parts by weight of folic acid, and 0.0001 to 0.0003 parts by weight of selenium.
상기 흑마늘은 본 발명에 따른 흑마늘이 함유된 건강보조식품 조성물의 주재료가 되는 성분으로 마늘의 매운맛과 특유의 자극취를 감소시키고 마늘 자체 성분의 반응에 따른 감미와 산미가 조화를 이루어 마늘의 섭취를 용이하게 하는 장점이 있으며, 유리당의 함량이 증가되고 산도가 낮아져 새콤달콤한 독특한 맛을 갖게 된다.The black garlic is a main ingredient of the health supplement composition containing black garlic according to the present invention, which reduces the spicy taste and peculiar pungent odor of garlic, and facilitates the intake of garlic by harmonizing the sweetness and acidity according to the reaction of the garlic itself. It has the advantage of making it, and the content of free sugar is increased and the acidity is lowered, resulting in a unique sweet and sour taste.
상기의 효과를 나타내는 흑마늘은 생마늘을 일정한 온도와 습도에서 장시간 숙성시키는 과정 중 비효소적 갈변반응에 의해 흑색으로 변화되는 과정을 통해 제조되며, 이때 생성된 갈색화 반응 물질은 높은 항산화 활성을 가진다. 또한 폴리 페놀류의함량 증가와 더불어 용출이 용이해지면서 S-알릴-시스테인(S-allyl-cysteine, SAC)과 같은 수용성의 유황아미노산인의 함량이 증가하여 일반 생마늘에 비해 항산화기능이 증가되고, 암 예방, 콜레스테롤 저하, 동맥경화 개선, 심장질환 예방, 산화스트레스와 관련된 효과 및 항염증 활성 등의 효과를 나타낼 뿐만 아니라, 정력을 개선하는 효과를 나타낸다.Black garlic exhibiting the above effects is prepared by aging raw garlic at a constant temperature and humidity for a long time and turning it black by a non-enzymatic browning reaction, and the browning reaction substance produced at this time has high antioxidant activity. In addition, as the content of polyphenols increases and the elution becomes easier, the content of water-soluble sulfur amino acids such as S-allyl-cysteine (SAC) increases, and the antioxidant function is increased compared to general raw garlic. It not only shows effects such as prevention, cholesterol lowering, arteriosclerosis improvement, heart disease prevention, oxidative stress-related effects and anti-inflammatory activity, but also shows an effect of improving stamina.
상기 L-아르기닌(L-Arginine)은 60 내지 70 중량부가 함유되며, 체내에서 질산(Nitric oxide)으로 전환되는 물질로서, 위점막의 평활근에 작용하여 혈관을 이완시키며, 주위 혈소판으로 침투해 혈소판 응집을 억제하여 혈류량을 증가시키고, 혈관내피점착과 점막 조직내로의 침착을 억제하고, 위점막보호작용이 뛰어나며, 호흡기계감염 등 여러 가지 감염증상 치료에 도움을 주는 물질이다.The L-arginine (L-Arginine) is contained in 60 to 70 parts by weight, and is a substance that is converted to nitric acid (Nitric oxide) in the body. It is a substance that increases blood flow by suppressing vascular endothelial adhesion and deposition into mucosal tissue, has excellent gastric mucosal protective action, and helps treat various infectious diseases such as respiratory infections.
따라서, 상기의 L-아르기닌이 함유되면 혈관이 이완되어 남성의 성기에 전달되는 혈류량이 증가하기 때문에 발기력을 개선할 수 있는데, 상기 L-아르기닌의 함량이 60 중량부 미만이면 상기의 효과가 미미하며, 상기 L-아르기닌의 함량이 70 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 상대적으로 다른 성분들의 함량이 줄어들기 때문에 바람직하지 못하다.Therefore, when the L-arginine is contained, the blood vessels are relaxed and the blood flow delivered to the male genital organs is increased, so that erection can be improved. , When the content of the L-arginine exceeds 70 parts by weight, it is not preferable because the content of other components is relatively reduced without significantly improving the above effect.
비타민 B 혼합물 0.3001 내지 0.701 중량부가 함유되며, 비타민 B1 0.1 내지 0.3 중량부, 비타민 B6 0.2 내지 0.4 중량부 및 비타민 B12 0.0001 내지 0.001 중량부로 이루어진다.0.3001 to 0.701 parts by weight of the vitamin B mixture is contained, consisting of 0.1 to 0.3 parts by weight of vitamin B1, 0.2 to 0.4 parts by weight of vitamin B6 and 0.0001 to 0.001 parts by weight of vitamin B12.
상기 비타민 B1은 체내 에너지를 생성하는 3대 영양소 중 하나인 탄수화물과 에너지 대사를 원활하게 하는 역할을 하는데, 비타민 B1이 부족하면 피로 물질인 젖산이 근육에 쌓이면서 쉽게 피곤하고 초조해지며, 식욕부진, 소화 장애, 정력 감퇴, 체중 감소와 같은 증상이 나타날 수 있다.The vitamin B1 plays a role in facilitating carbohydrate and energy metabolism, which is one of the three major nutrients that generate energy in the body. When vitamin B1 is lacking, lactic acid, a fatigue substance, accumulates in the muscles, making you easily tired and nervous, anorexia, digestion Symptoms such as disability, loss of energy, and weight loss may occur.
또한, 비타민 B6는 단백질 및 아미노산 이용에 필요적인 역할을 하며, 혈액에 호모시스테인을 정상으로 유지하는 역할을 하는데, 단백질 대사와 적혈구에서 산소를 운반하는 헤모글로빈 합성에 관여해 체지방 대사에 중요한 역할을 하기 때문에, 비타민 B6가 부족하면 피부염, 구내염, 구순염 및 우울증 등의 이상증상이 나타날 수 있다.In addition, vitamin B6 plays a necessary role in the use of proteins and amino acids, and plays a role in maintaining normal homocysteine in the blood. It is involved in protein metabolism and the synthesis of hemoglobin, which carries oxygen in red blood cells, and plays an important role in body fat metabolism. , Vitamin B6 deficiency can cause abnormal symptoms such as dermatitis, stomatitis, cheilitis and depression.
또한, 비타민 B12는 핵산 합성과 조혈 작용, 지방과 탄수화물의 대사에 관여하는데, 비타민 B12가 부족하면 DNA 합성이 정상적으로 이뤄지지 않아 적혈구 발달에 장애가 올 수 있고, 빈혈이 생길 수 있으며, 이 외에도 피로, 창백, 숨 가쁨, 운동 능력 감소 등의 증상과 신경 장애가 나타나기도 한다.In addition, vitamin B12 is involved in nucleic acid synthesis, hematopoiesis, and metabolism of fats and carbohydrates. If vitamin B12 is insufficient, DNA synthesis is not performed normally, which can lead to disorders in red blood cell development and anemia, as well as fatigue and paleness. Symptoms such as fatigue, shortness of breath, decreased motor skills, and neurological disorders may also occur.
따라서, 상기 비타민 B 혼합물의 함량이 0.3001 중량부 미만이면 본 발명에 따른 건강보조식품 조성물의 피로회복 효과가 저하되며, 상기 비타민 B1의 함량이 0.701 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 증가시키게 된다.Therefore, if the content of the vitamin B mixture is less than 0.3001 parts by weight, the fatigue recovery effect of the health supplement composition according to the present invention is reduced, and if the content of vitamin B1 exceeds 0.701 parts by weight, the effect is not greatly improved. will increase the manufacturing cost.
상기 니코틴산아미드는 4 내지 6 중량부가 함유되며, 항노화 효과를 부여하는 역할을 한다. 니코틴산아미드는 수용성 비타민 B3라고도 하며, 항펠라그라 작용을 통해 항노화 효과와 정력개선 효과를 나타낸다.The nicotinic acid amide is contained in an amount of 4 to 6 parts by weight and serves to impart an anti-aging effect. Nicotinic acid amide, also called water-soluble vitamin B3, exhibits anti-aging and energy-improving effects through anti-pellagra action.
더욱 상세하게는, 니코틴산아미드는 탄수화물과 지방산의 대사작용에 관여하면서 에너지 생성에 필요한 성분으로, 수많은 환원 반응에 관여할 뿐만 아니라, 콜레스테롤수치감소, 혈관건강, 피수의 수분유지 및 신경전달 물질의 생성 등의 역할을 하기 때문에, 항노화 효과와 혈관을 건강하게 하여 정력개선 효과를 나타내게 된다.More specifically, nicotinic acid amide is involved in the metabolism of carbohydrates and fatty acids and is a necessary component for energy generation. It is not only involved in numerous reduction reactions, but also reduces cholesterol levels, maintains blood vessel health, maintains water in the blood, and produces neurotransmitters. Because it plays a role such as anti-aging and blood vessels, it shows the effect of improving energy.
상기 판토텐산(Pantothenic acid)은 0.5 내지 1 중량부가 함유되며, 비타민 B5의 일종으로, 피로회복 효과를 나타낼 뿐만 아니라, 피부개선 및 탈모완화 등의 효과를 나타내는데, 상기 판토테산의 함량이 0.5 중량부 미만이면 상기의 효과가 미미하며, 상기 판토테산의 함량이 1 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 증가시키게 된다.The pantothenic acid is contained in an amount of 0.5 to 1 part by weight, and is a kind of vitamin B5. It not only shows a fatigue recovery effect, but also shows effects such as skin improvement and hair loss relief, and the content of pantothenic acid is less than 0.5 parts by weight If it is, the above effect is insignificant, and when the content of the pantothenic acid exceeds 1 part by weight, the above effect is not greatly improved, but the manufacturing cost increases.
상기 엽산은 0.01 내지 0.1 중량부가 함유되며, 비타민 B9에 속하는 성분으로, 호모시스테인 수치를 낮춰줄 뿐만 아니라, 허혈성 심장질환이나 뇌졸중을 발생율을 감소시켜주며, 새로운 세포와 혈액을 형성하는데 도움을 주고, 아미노산과 핵산의 합성에 필요한 영양소로 피로회복 및 정력개선 효과를 나타낸다.The folic acid is contained in an amount of 0.01 to 0.1 parts by weight, and is a component belonging to vitamin B9, which not only lowers homocysteine levels, but also reduces the incidence of ischemic heart disease or stroke, helps to form new cells and blood, and amino acids It is a nutrient necessary for the synthesis of nucleic acids and nucleic acids, and shows the effect of recovering from fatigue and improving energy.
상기 엽산의 함량이 0.01 중량부 미만이면 상기의 효과가 미미하며, 상기 엽산의 함량이 0.1 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 증가시키게 된다.If the content of folic acid is less than 0.01 part by weight, the above effect is insignificant, and if the content of folic acid exceeds 0.1 part by weight, the above effect is not greatly improved and the manufacturing cost is increased.
상기 셀레늄은 0.0001 내지 0.0003 중량부가 함유되며, 고등어와 같은 등 푸른 생선, 굴, 마늘, 양파, 깨, 버섯, 콩 등에 다량 함유되어 있는데, 남성 호르몬 생성과 관련이 있으며 항산화 효과가 있어 노화 방지 효과를 나타내는데, 취식자의 면역기능 향상과 정력을 개선하는 효과를 나타낸다.The selenium is contained in an amount of 0.0001 to 0.0003 parts by weight, and is contained in large amounts in blue fish such as mackerel, oysters, garlic, onions, sesame seeds, mushrooms, beans, etc., which is related to the production of male hormones and has an antioxidant effect to have an anti-aging effect. It shows the effect of improving the immune function and energy of eaters.
상기 셀레늄의 함량이 0.0001 중량부 미만이면 상기의 효과가 미미하며, 상기 셀레늄의 함량이 0.0003 중량부를 초과하게 되면 체내 흡수가능한 양보다 지나치게 다량이 함유되는 것으로 바람직하지 못하다.If the content of selenium is less than 0.0001 parts by weight, the above effect is insignificant, and if the content of selenium exceeds 0.0003 parts by weight, it is undesirably contained in an excessively large amount than the amount that can be absorbed by the body.
또한, 상기 흑마늘이 함유된 건강보조식품 조성물에는 상기 흑마늘 100 중량부 대비 녹골추출물 및 홍화추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어진 첨가제 1 내지 3 중량부가 더 함유될 수도 있는데, 상기와 같이 녹골추출물이나 홍화추출물로 이루어진 첨가제가 더 함유되면, 본 발명에 따른 흑마늘이 함유된 건강보조식품 조성물의 정력개선 및 피로회복 효과가 더욱 향상된다.In addition, the health supplement composition containing black garlic may further contain 1 to 3 parts by weight of an additive composed of one or more selected from the group consisting of a green bone extract and a safflower extract relative to 100 parts by weight of the black garlic. When an additive composed of safflower extract is further contained, the energy improvement and fatigue recovery effect of the health supplement composition containing black garlic according to the present invention is further improved.
상기 녹골추출물은 녹골 100 중량부에 정제수 500 내지 2000 중량부를 혼합하고 90 내지 100℃의 온도에서 5 내지 10시간 동안 열수추출한 후에, 열수추출된 유효성분을 여과하여 고형분의 형태로 제조된다.The Nokgol extract is prepared in the form of a solid by mixing 500 to 2000 parts by weight of purified water with 100 parts by weight of Nokgol, extracting with hot water at a temperature of 90 to 100 ° C. for 5 to 10 hours, and then filtering the active ingredient extracted with hot water.
녹골(鹿骨)은 혈액순환을 촉진하고 신체허약을 보하여 주며 소화기능을 도와줘 영양흡수를 촉진하므로 전신의 기능을 왕성하게 하는데, 특히 녹골에는 강글리오시드(ganglioside) 성분이 함유되어 있어 신경세포, 세포막의 기능에 유효하며 고환 등의 조직에 분포되어 신호전달에 관여하고 호르몬 등 생체물질의 수용체에 작용하는 것으로 알려져 있다. 즉, 녹골이 함유되면 신경이나 혈액순환장애 등 기질적인 원인을 회복시켜 기초체력을 증진시키기 때문에 정력개선 효과를 나타내게 된다.Nokgol promotes blood circulation, compensates for physical weakness, helps digestive function and promotes nutrient absorption, thus strengthening the body's functions. , it is effective for the function of cell membranes and is known to be distributed in tissues such as testis, involved in signal transmission, and acting on receptors of biological substances such as hormones. In other words, when green bone is contained, it restores organic causes such as nerves or blood circulation disorders and improves basic physical strength, so it shows the effect of improving energy.
또한, 상기 홍화추출물은 정력증강의 뛰어난 효과가 있으며, 피로 회복이나 숙면을 유도하는 역할을 하는데, 홍화분말을 열수추출하여 제조된다.In addition, the safflower extract has an excellent effect of enhancing energy, serves to induce fatigue recovery or sleep, and is prepared by hot-water extraction of safflower powder.
상기 홍화추출물은 바람직하게는 홍화꽃을 수집하여 그늘에서 2 내지 4일 동안 건조시켜 수분의 함량을 15 내지 25%로 조절한 후에 분말화하고, 분말화된 홍화분말 100 중량부에 정제수 500 내지 1000 중량부를 혼합한 후에 90 내지 100℃의 온도에서 60 내지 15분 동안 가열하여 유효성분을 열수추출하고, 열수추출된 성분을 상온으로 냉각한 후에 찌꺼기를 여과하여 1차 추출액 제조하고, 상기 1차 추출액을 감압농축하여 고형분으로 수득하는 과정을 통해 제조될 수 있다.The safflower extract is preferably collected and dried in the shade for 2 to 4 days to adjust the moisture content to 15 to 25%, and then powdered, and 500 to 1000 parts by weight of the powdered safflower powder in 500 to 1000 parts by weight of purified water. After mixing parts by weight, hot water extracts active ingredients by heating at a temperature of 90 to 100 ° C. for 60 to 15 minutes, cools the hot water extracted ingredients to room temperature, and filters the residue to prepare a first extract, and the first extract It can be prepared through a process of concentrating under reduced pressure to obtain a solid content.
상기와 같이 녹골추출물이나 홍화추출물로 이루어지는 첨가제의 함량이 1 중량부 미만이면 정력개선 및 피로회복 효과가 미미하며, 상기 첨가제의 함량이 3 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 지나치게 증가시키기 때문에 바람직하지 못하다.As described above, if the content of the additive composed of nogol extract or safflower extract is less than 1 part by weight, the effect of improving energy and recovering from fatigue is insignificant, and if the content of the additive exceeds 3 parts by weight, the above effect is not greatly improved. This is undesirable because it unduly increases the cost.
또한, 본 발명에 따른 블랙마카가 함유된 건강보조식품 조성물은 블랙마카, 밀크씨슬, 옥타코사놀, 아연, 비타민 혼합물로 이루어지며, 블랙마카 100 중량부, 밀크씨슬 40 내지 50 중량부, 옥타코사놀 3 내지 4 중량부, 아연 3 내지 4 중량부 및 비타민 혼합물 0.002 내지 0.003 중량부로 이루어지는 것이 바람직하다.In addition, the health supplement composition containing black maca according to the present invention is composed of a mixture of black maca, milk thistle, octacosanol, zinc, and vitamins, 100 parts by weight of black maca, 40 to 50 parts by weight of milk thistle, octacosanol 3 to 4 parts by weight, 3 to 4 parts by weight of zinc, and 0.002 to 0.003 parts by weight of a vitamin mixture.
상기 블랙마카는 본 발명에 따른 블랙마카가 함유된 건강보조식품 조성물의 주재료가 되는 성분으로, 발린, 라이신, 아르기닌 등의 필수 아미노산 10종과 비타민 C, E, B 등의 비타민 성분이 함유되어 있는데, 특히 아르기닌 성분의 경우 굴의 1.5배가 함유되어 있으며, 철분의 경우 더덕의 약 10배, 아연의 경우 부추의 약 11배, 칼슘의 경우에는 마늘의 약 26배가 함유되어 있다.The black maca is a main ingredient of the health supplement composition containing black maca according to the present invention, and contains 10 essential amino acids such as valine, lysine, and arginine, and vitamin components such as vitamins C, E, and B. In particular, it contains 1.5 times as much arginine as oysters, about 10 times as much iron as deodeok, about 11 times as much zinc as chives, and about 26 times as much calcium as garlic.
특히, 블랙마카의 경우, 천연 강장제나 천연 정력제로 호칭할 만큼 남성의 정력 개선효과가 탁월한데, 정자수와 정자의 활동성을 향상시키는 것으로 알려져 있으며, 이 외에도 섭취자의 운동능력을 향상시키는 효과를 나타낸다.In particular, in the case of black maca, it has an excellent effect on improving male virility to the extent that it is called a natural tonic or a natural stamina agent. .
이때, 상기 블랙마카의 경우 체내 흡수율을 향상시키기 위해 마카의 영양성분은 유지되면서 블랙마카에 함유된 전분을 제거하는 젤라틴화공정을 통해 젤라틴화된 블랙마카를 사용하는 것이 더욱 바람지하다.At this time, in the case of the black maca, it is more preferable to use gelatinized black maca through a gelatinization process to remove the starch contained in black maca while maintaining the nutrients of maca to improve the absorption rate in the body.
상기 밀크씨슬은 40 내지 50 중량부가 함유되며, 피로회복 효과를 부여하는 역할을 하는데, 더욱 상세하게는 간은 체내에서 지방을분해하는 담즙산 생산이나 유해균을 사멸시키는 쿠퍼세포 간재생, 영양분의 저장과 배출작용 등의 많은 일을 하는데, 상기의 간기능은 음주나 흡연 등의 행위를 통해 체내에 유해물들이 쌓이면서 피로를 느끼게 되고, 그 기능이 저하되게 되는데 밀크씨슬에 함유된 실리마린 성분은 간기능 회복, 간세포재생 및 몸의 피로감을 줄여주는데 도움을 준다.The milk thistle is contained in an amount of 40 to 50 parts by weight, and serves to provide a fatigue recovery effect. More specifically, the liver produces bile acids that decompose fat in the body, Kupffer cell liver regeneration that kills harmful bacteria, and storage of nutrients. It does a lot of work, such as excretion, and the liver function is fatigued as harmful substances accumulate in the body through acts such as drinking or smoking, and its function is reduced. The silymarin component contained in milk thistle is It helps to recover, regenerate liver cells and reduce body fatigue.
따라서, 밀크씨슬이 함유되면 간기능이 개선되어 피로회복효과를 나타내게 되는데, 상기 밀크씨슬의 함량이 40 중량부 미만이면 상기의 효과가 미미하다.Therefore, when milk thistle is contained, liver function is improved to show a fatigue recovery effect. If the content of milk thistle is less than 40 parts by weight, the above effect is insignificant.
상기 옥타코사놀은 3 내지 4 중량부가 함유되며, 혈액 내 산소운반 기능을 향상시켜 적은 양으로도 호흡곤란을 일으키지 않게 하며 심장 박동수가 적어도 쉽게 지치지 않도록 해주는 역할을 하며, 혈압조절 작용과 체지방을 쉽게 연소시키는 체지방 연소 촉매제 역할을 하므로 비만해소작용이 있다. 또 항 스트레스작용, 체력증진작용, 정력증진작용, 지구력증진작용 및 에너지대사촉진작용 등을 나타낸다.The octacosanol contains 3 to 4 parts by weight, improves the oxygen transport function in the blood so as not to cause shortness of breath even in a small amount, and serves to prevent fatigue at least with a low heart rate, and has a blood pressure control action and easily burns body fat It acts as a catalyst for burning body fat, so it has an effect of eliminating obesity. In addition, it exhibits anti-stress action, physical strength enhancing action, energy enhancing action, endurance enhancing action, and energy metabolism promoting action.
상기 아연은 3 내지 4 중량부가 함유되며, 정자운동을 활발하게 하고 전립선의 기능을 개선하는 역할을 하는데, 탈모예방과 치료에도 효과를 나타낸다.The zinc is contained in 3 to 4 parts by weight, serves to activate sperm movement and improve prostate function, and is also effective in preventing and treating hair loss.
즉, 아연이 직접적으로 정력개선 효과를 나타내지는 않지만, 전립선의 기능을 개선하여 정력개선 효과를 보조적으로 지원하는 역할을 한다.In other words, zinc does not directly show the effect of improving stamina, but it serves to supplementally support the effect of improving stamina by improving the function of the prostate.
상기 비타민 혼합물은 0.002 내지 0.003 중량부가 함유되며, 비타민 D3 0.0015 내지 0.0025 중량부 및 비타민 E 0.0005 내지 0.005 중량부로 이루어진다.The vitamin mixture contains 0.002 to 0.003 parts by weight, and consists of 0.0015 to 0.0025 parts by weight of vitamin D3 and 0.0005 to 0.005 parts by weight of vitamin E.
상기 비타민 D3는 체내에 칼슘과 인 성분이 흡수되는데 필요한 성분으로, 뼈의 형성과 유지에 필요하며, 골다공증발생의 위험을 감소시키는 역할을 하며, 상기 비타민 E는 노화방지, 피부미용, 혈액순환 및 항산화 등 다양한 효능을 나타내는데, 상기와 같이 비타민 D3 및 비타민 E로 이루어진 비타민 혼합물이 함유되면 체력증진 및 혈액순화 등이 개선되어 피로회복 효과가 향상된다.The vitamin D3 is a component necessary for the absorption of calcium and phosphorus components in the body, is necessary for the formation and maintenance of bones, and serves to reduce the risk of osteoporosis, and the vitamin E is anti-aging, skin beauty, blood circulation and It exhibits various effects such as antioxidant. As described above, when the vitamin mixture consisting of vitamin D3 and vitamin E is contained, physical strength and blood circulation are improved, and the fatigue recovery effect is improved.
또한, 상기 블랙마카가 함유된 건강보조식품 조성물에는 상기 블랙마카 100 중량부 대비 캐롭추출물 1 내지 3 중량부가 더 함유될 수 있는데, 상기와 같이 캐롭추출물이 함유되면, 테스토스테로 저하로 인해 갱년기 남성에게서 빈번하게 발생하는 전립선 비대증, 하부요로증상, 신경과민, 정서불안, 우울증, 안면홍조, 수면장애, 활력저하, 업무능력감소, 성욕감퇴, 발기부전, 정력감소, 체력저하, 운동능력감소, 체모감소와 같은 증상들이 개선된다.In addition, the health supplement composition containing black maca may further contain 1 to 3 parts by weight of carob extract relative to 100 parts by weight of black maca. Prostatic hyperplasia, lower urinary tract symptoms, nervousness, emotional instability, depression, hot flashes, sleep disorders, decreased vitality, decreased work ability, decreased libido, impotence, decreased energy, decreased physical strength, reduced exercise capacity, body hair Symptoms such as reduction are improved.
이때, 상기 캐롭추출물은 캐롭을 선별하여 분쇄한 후에, 상기 분쇄물 100 중량부 대비 100 내지 2000 중량부의 용매(물, 메탄올, 에탄올, 부탄올 등의 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용 매로부터 선택된 용매)를 혼합하고 50 내지 100℃의 온도에서 2 내지 8시간 동안 가열하여 추출물을 제조한 후에, 상기 추출물을 여과하고 진공농축한 후에 동결 건조하는 과정을 통해 제조될 수 있다.At this time, the carob extract is selected and pulverized, and then 100 to 2000 parts by weight of solvent (lower alcohol having 1 to 4 carbon atoms such as water, methanol, ethanol, butanol or a mixture thereof) based on 100 parts by weight of the pulverized product After preparing an extract by mixing a solvent selected from) and heating at a temperature of 50 to 100 ° C. for 2 to 8 hours, the extract may be prepared by filtering, vacuum concentration, and freeze-drying.
또한, 본 발명에 따른 건강보조식품 조성물의 섭취방법은 상기 흑마늘이 함유된 건강보조식품 조성물과 상기 블랙마카가 함유된 건강보조식품 조성물을 섭취하는 방법에 관한 것인데, 상기 건강보조식품 조성물 들에 함유된 유효성분의 체내 흡수율을 향상시키기 위해, 상기 두 가지의 건강보조식품 조성물을 한번에 섭취하는 것이 아니라, 상기 흑마늘이 함유된 건강보조식품 조성물 0.9 내지 1.1g을 섭취하고 약 10 내지 14시간 후에, 청구항 5 내지 8 중 어느 한 항에 따른 블랙마카가 함유된 건강보조식품 조성물 0.8 내지 1g을 섭취하는 과정으로 이루어지는 것이 바람직하다.In addition, the method of ingesting the health supplement composition according to the present invention relates to a method of ingesting the health supplement composition containing the black garlic and the health supplement composition containing the black maca. In order to improve the body absorption rate of the active ingredient, claim 10 to 14 hours after ingesting 0.9 to 1.1 g of the health supplement composition containing the black garlic, rather than ingesting the two health supplement compositions at once. It is preferable to consist of a process of ingesting 0.8 to 1 g of the health supplement composition containing black maca according to any one of 5 to 8.
상기의 과정으로 흑마늘이 함유된 건강보조식품 조성물과 블랙마카가 함유된 건강보조식품 조성물을 교차 섭취하게 되면, 상기의 건강보조식품 조성물 들에 함유된 성분들의 체내 효율이 증가하여 피로회복 및 정력개선 효과가 더욱 향상된다.When the health supplement composition containing black garlic and the health supplement composition containing black maca are alternately consumed through the above process, the efficiency of the components contained in the above health supplement compositions increases in the body to recover from fatigue and improve energy. effect is further enhanced.
또한, 상기와 같은 조건에서 교차로 섭취하게 되면 원료 성분간 충돌현상이 억제되어 안정성이 보장된다. 특히, 흑마늘에 함유된 알리신의 경우 비타민 B군과 엽산의 체내 흡수율을 높여주고, 밀크씨슬과 비타민 D도 동일한 작용을 하게 되지만, 정제된 셀레늄과 아연의 경우 동시섭취를 하게 되면 서로 흡수되려고 하는 성질로 인해 전체적인 흡수율을 저하시키게 된다.In addition, when consumed alternately under the above conditions, the collision between the raw material components is suppressed and stability is ensured. In particular, allicin contained in black garlic increases the absorption rate of vitamin B group and folic acid in the body, and milk thistle and vitamin D have the same effect. Due to its properties, the overall absorption rate is lowered.
또한, 상기의 성분으로 이루어지는 흑마늘이 함유된 건강보조식품 조성물은 주간에 활동하는데 필요한 에너지원이 다량 함유되어 있는데, 공복에 흡수율이 높은 성분들이 주를 이루기 때문에 공복상태인 오전 6시에서 8시 사이에 섭취하는 것이 바람직하다.In addition, the health supplement composition containing black garlic composed of the above components contains a large amount of energy sources necessary for daytime activity. It is preferable to consume
특히, 상기의 성분으로 이루어지는 흑마늘이 함유된 건강보조식품 조성물에 함유된 흑마늘과 L-아르기닌은 공복섭취시 유효성분의 흡수율이 월등하게 향상된다.In particular, black garlic and L-arginine contained in the black garlic-containing health supplement composition comprising the above ingredients significantly improve the absorption rate of active ingredients when taken on an empty stomach.
반면, 상기의 블랙마카가 함유된 건강보조식품 조성물은 야간 수면과정 중에 인체에 작용하는 성분이 함유되어 있고, 밀크씨슬이나 아연의 경우 공복에 섭취하게 되면 불쾌감을 유발할 수 있으며, 비타민 D,E성분은 지용성으로 식후에 섭취해야 음식물에 함유된 영양성분과 함께 체내에 원활하게 흡수되기 때문에, 오후 6시에서 8시 사이에 섭취하는 것이 바람직하다.On the other hand , the health supplement composition containing black maca contains ingredients that act on the human body during nighttime sleep, and milk thistle or zinc can cause discomfort when taken on an empty stomach, and vitamins D and E Ingredients are fat-soluble and must be taken after meals to be smoothly absorbed into the body along with nutrients contained in food, so it is desirable to take them between 6 and 8 pm .
상기 흑마늘이 함유된 건강보조식품 조성물에 함유된 비타민 B 혼합물과 엽산을 섭취하게 되면 신진대사를 높여주고 섭취한 음식의 에너지 전환율을 향상시키지만, 저녁에 섭취하게 되면 신진대사가 지나치게 활발해져 불면증을 유발할 수 있다.When the vitamin B mixture and folic acid contained in the health supplement composition containing black garlic are consumed, metabolism is increased and the energy conversion rate of the ingested food is improved. there is.
또한, 상기와 같은 흑마늘이 함유된 건강보조식품 조성물과 블랙마카가 함유된 건강보조식품 조성물은 보관 및 섭취를 간편하게 하기 위해 아래 도 1에 나타낸 보관케이스(10)를 이용하여 휴대하는 것이 바람직하다.In addition, it is preferable to carry the health supplement composition containing black garlic and the health supplement food composition containing black maca as described above using a
아래 도 1에 나타낸 것처럼, 성분이 서로 다른 건강보조식품 조성물이 각각 담긴 제1보관용기(11) 및 제2보관용기(12)를 개재할 수 있는 보관케이스(10)에 제1보관용기(11) 및 제2보관용기(12)가 각각 개재되면, 장소에 구애 받지 않고 아침과 저녁에 본 발명에 따른 흑마늘이 함유된 건강보조식품 조성물과 블랙마카가 함유된 건강보조식품 조성물을 간편하게 섭취할 수 있다.As shown in FIG. 1 below, the
이하에서는, 본 발명에 따른 건강보조식품 조성물의 제조방법 및 그 제조방법을 통해 제조된 건강보조식품의 물성을 실시예를 들어 설명하기로 한다.Hereinafter, the manufacturing method of the health supplement composition according to the present invention and the physical properties of the health supplement prepared through the manufacturing method will be described with examples.
<제조예 1> 흑마늘이 함유된 건강보조식품 조성물의 제조<Preparation Example 1> Preparation of health supplement composition containing black garlic
흑마늘 600mg, L-아르기닌 396mg, 비타민 B1 1.2mg, 니코틴산아미드 30mg, 판토텐산 4.8mg, 비타민 B6 1.56mg, 엽산 360㎍, 비타민 B12 2.4㎍ 및 셀레늄 1.1㎍을 혼합하고 제환기를 이용하여 환 형태의 흑마늘이 함유된 건강보조식품 조성물을 제조하였다.Black garlic 600mg, L-arginine 396mg, vitamin B1 1.2mg, nicotinic acid amide 30mg, pantothenic acid 4.8mg, vitamin B6 1.56mg, folic acid 360μg, vitamin B12 2.4μg, and selenium 1.1μg were mixed and black garlic in a pill form using a ventilation device. A health supplement composition containing this was prepared.
<제조예 2> 흑마늘이 함유된 건강보조식품 조성물의 제조<Preparation Example 2> Preparation of health supplement composition containing black garlic
상기 제조예 1과 동일하게 진행하되, 녹골추출물 6mg 및 홍화추출물 6mg을 더 혼합하여 흑마늘이 함유된 건강보조식품 조성물을 제조하였다.Proceed in the same manner as in Preparation Example 1, but further mixing 6 mg of green bone extract and 6 mg of safflower extract to prepare a health supplement composition containing black garlic.
<제조예 3> 블랙마카가 함유된 건강보조식품 조성물의 제조<Preparation Example 3> Preparation of health supplement composition containing black maca
블랙마카 597.6mg, 밀크씨슬 279.6mg, 옥타코사놀 20.4mg, 아연 20.4mg, 비타민 D3 12㎍ 및 비타민 E 3㎍을 혼합하고 제환기를 이용하여 환 형태의 블랙마카가 함유된 건강보조식품 조성물을 제조하였다.Black maca 597.6mg, milk thistle 279.6mg, octacosanol 20.4mg, zinc 20.4mg, vitamin D3 12μg, and vitamin E 3μg were mixed and a health supplement composition containing black maca in a pill form was prepared using a ventilator. did
<제조예 4> 블랙마카가 함유된 건강보조식품 조성물의 제조<Preparation Example 4> Preparation of health supplement composition containing black maca
상기 제조예 3과 동일하게 진행하되, 캐롭추출물 12mg을 더 혼합하여 블랙마카가 함유된 건강보조식품 조성물을 제조하였다.Proceed in the same manner as in Preparation Example 3, but 12 mg of carob extract was further mixed to prepare a health supplement composition containing black maca.
<실시예 1><Example 1>
상기 제조예 1을 통해 제조된 흑마늘이 함유된 건강보조식품 조성물을 2정을 섭취(오전 7시)하고 약 12시간 후에, 상기 제조예 3을 통해 제조된 블랙마카가 함유된 건강보조식품 조성물을 2정을 섭취(오후 7시)하는 과정을 한달간 반복하였다.About 12 hours after taking 2 tablets of the health supplement composition containing black garlic prepared in Preparation Example 1 (7:00 am), the health supplement composition containing black garlic prepared in Preparation Example 3 The process of taking 2 tablets (at 7 pm) was repeated for one month.
<실시예 2><Example 2>
상기 제조예 2를 통해 제조된 흑마늘이 함유된 건강보조식품 조성물을 2정을 섭취(오전 7시)하고 약 12시간 후에, 상기 제조예 4를 통해 제조된 블랙마카가 함유된 건강보조식품 조성물을 2정을 섭취(오후 7시)하는 과정을 한달간 반복하였다.About 12 hours after taking 2 tablets of the health supplement composition containing black garlic prepared in Preparation Example 2 (7:00 am), the health supplement composition containing black garlic prepared in Preparation Example 4 The process of taking 2 tablets (at 7 pm) was repeated for one month.
<비교예 1><Comparative Example 1>
상기 제조예 1을 통해 제조된 흑마늘이 함유된 건강보조식품 조성물과 상기 제조예 3을 통해 제조된 블랙마카가 함유된 건강보조식품 조성물 4정을을 동시에 섭취(1일 1회)하는 과정을 한달간 반복하였다.The process of simultaneously ingesting (once a day) the health supplement composition containing black garlic prepared through Preparation Example 1 and the health supplement composition containing black maca prepared through Preparation Example 3 at the same time for one month repeated.
<비교예 2><Comparative Example 2>
상기 제조예 2을 통해 제조된 흑마늘이 함유된 건강보조식품 조성물과 상기 제조예 4를 통해 제조된 블랙마카가 함유된 건강보조식품 조성물 4정을 동시에 섭취(1일 1회)하는 과정을 한달간 반복하였다.The process of simultaneously ingesting the health supplement composition containing black garlic prepared through Preparation Example 2 and the health supplement composition containing black maca prepared through Preparation Example 4 at the same time (once a day) was repeated for one month. did
상기 실시예 1 내지 2 및 비교예 1 내지 2를 통해 건강보조식품을 섭취한 후에 효능을 측정하여 아래 표 1에 나타내었다.After taking the health supplement through Examples 1 to 2 and Comparative Examples 1 to 2, the efficacy was measured and shown in Table 1 below.
{단, 효능은 피로회복 및 정력개선이며,{However, the efficacy is fatigue recovery and energy improvement,
피로회복은 피시험자 100명을 대상으로 하여 실시예 1 내지 2 및 비교예 1 내지 2를 각 25명씩 한달 동안 실시한 후에 실시 전과 비교하여 5점 척도법으로 조사한 후에 평균값으로 나타내었으며,Fatigue recovery was conducted on 100 test subjects for Examples 1 to 2 and Comparative Examples 1 to 2 for 25 people each for one month, and then compared with before implementation with a 5-point scale.
정력개선은 피시험자 80명을 대상으로 하여 실시예 1 내지 2 및 비교예 1 내지 2를 실시하는 과정에서 주 1회 성관계를 실시하도록 한 후에 실시 전과 성관계 지속시간 및 만족도를 비교하여 5점 척도법으로 조사한 후에 평균값으로 나타내었다.Vigor improvement was conducted on 80 test subjects to have sexual intercourse once a week in the process of conducting Examples 1 and 2 and Comparative Examples 1 and 2, and then compared the duration and satisfaction of sexual intercourse before and after the 5-point scale method. After investigation, it was expressed as an average value.
5점:매우개선, 4점:개선, 3점:변화없음, 2점:악화, 1점:매우 악화}5 points: very improved, 4 points: improved, 3 points: no change, 2 points: worse, 1 point: very worse}
<표 1><Table 1>
상기 표 1에 나타낸 것처럼, 본 발명의 건강보조식품 조성물은 피로회복 및 정력개선 효과가 우수한 것을 알 수 있다.As shown in Table 1, it can be seen that the health supplement composition of the present invention has excellent fatigue recovery and energy improvement effects.
또한, 실시예 1 내지 2와 같이 흑마늘이 함유된 건강보조식품 조성물과 블랙마카가 함유된 건강보조식품 조성물을 12시간 간격으로 교차 섭취한 경우는 비교예 1 내지 2와 같이 한번에 섭취하는 경우보다 피로회복 및 정력개선 효과가 더욱 향상되는 것을 알 수 있다.In addition, when the health supplement composition containing black garlic and the health supplement composition containing black maca were alternately consumed at intervals of 12 hours as in Examples 1 and 2, fatigue was higher than that when ingested at once as in Comparative Examples 1 and 2. It can be seen that the effect of recovery and improvement of energy is further improved.
따라서, 본 발명에 따른 건강보조식품 조성물 및 그 조성물의 섭취방법은 영양성분이 풍부하게 함유되어 있을 뿐만 아니라, 취식자의 피로를 회복시키고 정력을 개선하는 탁월한 효과를 나타낸다.Therefore, the health supplement composition and the method of ingesting the composition according to the present invention are not only rich in nutrients, but also show excellent effects of recovering the fatigue of eaters and improving their stamina.
10 ; 보관케이스
11 ; 제1보관용기
12 ; 제2보관용기10; storage case
11; 1st storage container
12; 2nd storage container
Claims (9)
A health supplement composition containing black garlic, characterized in that it consists of black garlic, L-arginine, vitamin B mixture, nicotinic acid amide, pantothenic acid, folic acid and selenium.
상기 흑마늘이 함유된 건강보조식품 조성물은 흑마늘 100 중량부, L-아르기닌 60 내지 70 중량부, 비타민 B 혼합물 0.3001 내지 0.701 중량부, 니코틴산아미드 4 내지 6 중량부, 판토텐산 0.5 내지 1 중량부, 엽산 0.01 내지 0.1 중량부 및 셀레늄 0.0001 내지 0.0003 중량부로 이루어지는 것을 특징으로 하는 흑마늘이 함유된 건강보조식품 조성물.
The method of claim 1,
The health supplement composition containing black garlic is black garlic 100 parts by weight, L-arginine 60 to 70 parts by weight, vitamin B mixture 0.3001 to 0.701 parts by weight, nicotinic acid amide 4 to 6 parts by weight, pantothenic acid 0.5 to 1 parts by weight, folic acid 0.01 to 0.1 parts by weight and 0.0001 to 0.0003 parts by weight of selenium.
상기 비타민 B 혼합물은 비타민 B1 0.1 내지 0.3 중량부, 비타민 B6 0.2 내지 0.4 중량부 및 비타민 B12 0.0001 내지 0.001 중량부로 이루어지는 것을 특징으로 하는 흑마늘이 함유된 건강보조식품 조성물.
The method of claim 1,
The vitamin B mixture is a health supplement composition containing black garlic, characterized in that consisting of 0.1 to 0.3 parts by weight of vitamin B1, 0.2 to 0.4 parts by weight of vitamin B6 and 0.0001 to 0.001 parts by weight of vitamin B12.
상기 흑마늘이 함유된 건강보조식품 조성물에는 상기 흑마늘 100 중량부 대비 녹골추출물 및 홍화추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어진 첨가제 1 내지 3 중량부가 더 함유되는 것을 특징으로 하는 흑마늘이 함유된 건강보조식품 조성물.
The method of claim 2,
The health supplement composition containing black garlic further contains 1 to 3 parts by weight of an additive consisting of at least one selected from the group consisting of green bone extract and safflower extract relative to 100 parts by weight of the black garlic. composition.
A health supplement composition containing black maca, characterized in that it consists of a mixture of black maca, milk thistle, octacosanol, zinc, and vitamins.
상기 블랙마카가 함유된 건강보조식품 조성물은 블랙마카 100 중량부, 밀크씨슬 40 내지 50 중량부, 옥타코사놀 3 내지 4 중량부, 아연 3 내지 4 중량부 및 비타민 혼합물 0.002 내지 0.003 중량부로 이루어지는 것을 특징으로 하는 블랙마카가 함유된 건강보조식품 조성물.
The method of claim 5,
The health supplement composition containing black maca is composed of 100 parts by weight of black maca, 40 to 50 parts by weight of milk thistle, 3 to 4 parts by weight of octacosanol, 3 to 4 parts by weight of zinc, and 0.002 to 0.003 parts by weight of a vitamin mixture. A health supplement composition containing black maca.
상기 비타민 혼합물은 비타민 D3 0.0015 내지 0.0025 중량부 및 비타민 E 0.0005 내지 0.005 중량부로 이루어지는 것을 특징으로 하는 블랙마카가 함유된 건강보조식품 조성물.
The method of claim 5,
The vitamin mixture is a health supplement composition containing black maca, characterized in that consisting of 0.0015 to 0.0025 parts by weight of vitamin D3 and 0.0005 to 0.005 parts by weight of vitamin E.
상기 블랙마카가 함유된 건강보조식품 조성물에는 상기 블랙마카 100 중량부 대비 캐롭추출물 1 내지 3 중량부가 더 함유되는 것을 특징으로 하는 블랙마카가 함유된 건강보조식품 조성물.
The method of claim 6,
Health supplement composition containing black maca, characterized in that the health supplement composition containing black maca further contains 1 to 3 parts by weight of carob extract relative to 100 parts by weight of black maca.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210076281A KR20220167128A (en) | 2021-06-11 | 2021-06-11 | Health assistance food composition showing fatigue recovery and energy improvement effect and intake method of the composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210076281A KR20220167128A (en) | 2021-06-11 | 2021-06-11 | Health assistance food composition showing fatigue recovery and energy improvement effect and intake method of the composition |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220167128A true KR20220167128A (en) | 2022-12-20 |
Family
ID=84539046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210076281A KR20220167128A (en) | 2021-06-11 | 2021-06-11 | Health assistance food composition showing fatigue recovery and energy improvement effect and intake method of the composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220167128A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030017923A (en) | 2001-08-25 | 2003-03-04 | 주식회사 한국의과학연구소 | Drugs manufacturing method and composite to reinforce vigor |
KR101955070B1 (en) | 2016-08-26 | 2019-03-06 | 이영근 | Health underpants |
-
2021
- 2021-06-11 KR KR1020210076281A patent/KR20220167128A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030017923A (en) | 2001-08-25 | 2003-03-04 | 주식회사 한국의과학연구소 | Drugs manufacturing method and composite to reinforce vigor |
KR101955070B1 (en) | 2016-08-26 | 2019-03-06 | 이영근 | Health underpants |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090110674A1 (en) | Health supplement | |
CN104223107B (en) | A kind of health products of liver-protecting and alcoholism-relieving toxin expelling | |
CN103725469B (en) | A kind of health dry red winew | |
KR20070054739A (en) | Total enteral nutritious composition | |
CN105211863A (en) | A kind of composition and mountain, ginger jujube Huaihe River ferment thereof making mountain, ginger jujube Huaihe River ferment | |
JP2013501778A (en) | HEALTH SUPPLEMENTAL, FEED, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME CONTAINING CHIASEED AND MACA | |
JP2012171901A (en) | Food for oral-intake for hair growth of men | |
CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
CN103190483A (en) | Children growth promotion milk tea | |
CN103431395A (en) | Fruit/vegetable buccal tablet for alleviating hangover and preparation technique thereof | |
CN104824674A (en) | Nutrient health-care food for preventing and treating alopecia | |
WO2008095093A2 (en) | Method of increasing cellular function and health of glutathione deficient animals | |
CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
KR101716766B1 (en) | How to breed crickets and food composition comprising the crickets | |
EP2184069A1 (en) | Natural alcohol detoxication treatment, gradual weaning with long-term complete abstinence. | |
CN105249440A (en) | Donkey-hide gelatin cake | |
CN100574786C (en) | A kind of production technology of tortoise preparation | |
JP2006197911A (en) | Health food using bee larva | |
KR20220167128A (en) | Health assistance food composition showing fatigue recovery and energy improvement effect and intake method of the composition | |
CN108095075A (en) | Miscarriage women tailored version clinical nutrition formula and preparation method thereof | |
CN114947138A (en) | Milk calcium composition for preventing and improving calcium deficiency disease, and preparation method and application thereof | |
CN103431396A (en) | Natural plant buccal tablet for and preparation technique thereof | |
KR102322276B1 (en) | Beverage composition for preventing obesity and relieving edema | |
CN106173822A (en) | High-grade ginseng fruit anemia of pregnant woman's nutritive powder puerperal period | |
FR2916637A1 (en) | Composition, useful to prepare functional food/food supplement to prevent e.g. chronic disorder of alcoholism, comprises extract mixture of five plants comprising German Chamomile, Melissa, Horsetail, Milk Thistle, Echinacea, and excipient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |